Background Abstract The severe acute respiratory syndrome (SARS) has recently been
identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. …

Background The worldwide outbreak of severe acute respiratory syndrome (SARS) is
associated with a newly discovered coronavirus, SARS-associated coronavirus (SARSCoV). We …

Influenza A is a highly contagious single-stranded RNA virus that infects both the upper and
lower respiratory tracts of humans. The host innate immune Toll-like receptor (TLR) 3 was …

Influenza A virus (IAV) is the etiological agent of a highly contagious acute respiratory disease
that causes epidemics and considerable mortality annually. Recently, we demonstrated, …

It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …

Public health measures successfully contained outbreaks of the severe acute respiratory
syndrome coronavirus (SARS-CoV) infection. However, the precursor of the SARS-CoV …

Post-translational modifications and correct subcellular localization of viral structural proteins
are prerequisites for assembly and budding of enveloped viruses. Coronaviruses, like the …

Crosspresentation is a specialized function of myeloid dendritic cells (mDCs), allowing them
to induce CD8 + T cell responses against exogenous antigens that are not directly …

In March 2020, a severe respiratory syndrome developed in a cat, 1 week after its owner
received positive test results for severe acute respiratory syndrome coronavirus 2. Viral RNA …

Cross-presentation is a crucial mechanism in tumoral and microbial immunity because it
allows internalized cell associated or exogenous antigens (Ags) to be delivered into the major …